NCT06203652Recruiting
The Pathogenesis and Prognostic Factors of Lymphoma
Source: ClinicalTrials.gov · Last updated 12 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 2 Jan 2024
- Start date
- 5 Jun 2023
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Shanghai Zhongshan Hospital
- Diseases
- Hodgkin lymphoma, Childhood cancers
- NCT number
- NCT06203652
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 5 Jun 2023 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe mental illness.
Age
- Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period.
Other
- Patients deemed unsuitable for inclusion by the investigator.
Who the study is looking for
- Patients with pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lyphoma, eg. THRLBCL, DLBCL, MZL, CLL/SLL...) from 2007 to 2027.
- Patients with complete diagnostic, treatment and follow-up records.
- Fully comprehension and signature of the informed consent form (ICF) for participation.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhongshan Hospital,Fudan University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.